Terms: = Germ cell tumor AND ENO2, HEL-S-279, NSE AND Clinical Outcome
6 results:
1. Early Decline of Neuron-Specific Enolase during Neuroblastoma Chemotherapy is a Predictive Factor of clinical outcome.
Zhu FY; Yan J; Cao YN; Jin Y; Li J; Zhao Q
Pediatr Hematol Oncol; 2021 Sep; 38(6):543-554. PubMed ID: 34106032
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma.
Sanzey M; Abdul Rahim SA; Oudin A; Dirkse A; Kaoma T; Vallar L; Herold-Mende C; Bjerkvig R; Golebiewska A; Niclou SP
PLoS One; 2015; 10(5):e0123544. PubMed ID: 25932951
[TBL] [Abstract] [Full Text] [Related]
3. Vasoactive intestinal peptide induces neuroendocrine differentiation in the LNCaP prostate cancer cell line through PKA, ERK, and PI3K.
Gutiérrez-Cañas I; Juarranz MG; Collado B; Rodríguez-Henche N; Chiloeches A; Prieto JC; Carmena MJ
Prostate; 2005 Apr; 63(1):44-55. PubMed ID: 15468165
[TBL] [Abstract] [Full Text] [Related]
4. Paraganglioma of the cauda equina. A case report and review of the literature.
Bak J; Olsson Y; Grimelius L; Spännare B
APMIS; 1996 Mar; 104(3):234-40. PubMed ID: 8611199
[TBL] [Abstract] [Full Text] [Related]
5. Melanotic neuroectodermal tumor of infancy (MNTI) in the epididymis. A case report with immunohistological studies and special consideration of malignant features.
Jurincic-Winkler C; Metz KA; Klippel KF
Zentralbl Pathol; 1994 Jul; 140(2):181-5. PubMed ID: 7947625
[TBL] [Abstract] [Full Text] [Related]
6. Paragangliomas: assessment of prognosis by histologic, immunohistochemical, and ultrastructural techniques.
Kliewer KE; Wen DR; Cancilla PA; Cochran AJ
Hum Pathol; 1989 Jan; 20(1):29-39. PubMed ID: 2912871
[TBL] [Abstract] [Full Text] [Related]
